IZEA Worldwide (IZEA) director receives $15,000 restricted stock grant
Rhea-AI Filing Summary
Bonchristiano Antonio reported acquisition or exercise transactions in this Form 4 filing.
IZEA Worldwide director Antonio Bonchristiano received a stock-based fee for board service. He was granted 4,054 shares of common stock as restricted stock for Q2 2026 director fees, valued at $15,000 based on a closing price of $3.70 on June 30, 2026. The award vested immediately on the grant date, and his direct holdings after the grant totaled 35,738 shares of common stock.
Positive
- None.
Negative
- None.
Insights
Routine director stock grant compensates board service with immediate vesting.
Director Antonio Bonchristiano received 4,054 restricted shares of IZEA Worldwide common stock as Q2 2026 director fees, valued at $15,000 using the $3.70 closing price on June 30, 2026. This is compensation, not an open-market purchase.
The grant vested immediately, so the shares are fully owned rather than subject to future service conditions. After this award, his direct holdings rose to 35,738 shares. As a standard equity fee for board service, this event is generally neutral for shareholders and does not materially change the investment thesis.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,054 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock received for Q2 2026 director fees valued at $15,000 based on the closing market price of $3.70 on the grant date of June 30, 2026. Award vests immediately at the grant date.
Key Figures
Key Terms
Restricted Stock financial
director fees financial
grant date financial
vests immediately financial
Form 4 regulatory
FAQ
What did Antonio Bonchristiano receive in IZEA (IZEA) stock on June 30, 2026?
How was the IZEA (IZEA) director stock grant valued in this Form 4?
Did the IZEA (IZEA) director stock award have a vesting schedule?
Was this IZEA (IZEA) Form 4 a market purchase or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.